NIHR Global Health Research Unit on Global Surgery, Institute of Translational Medicine, Birmingham, UK.
Reconstructive Surgery and Regenerative Medicine Research Centre, Institute of Life Sciences, Swansea University Medical School, Swansea, UK; Welsh Centre for Burns and Plastic Surgery, Morriston Hospital, Swansea, UK.
Br J Anaesth. 2022 Jun;128(6):909-911. doi: 10.1016/j.bja.2022.03.003. Epub 2022 Mar 10.
Current or recent infection with SARS-CoV-2 increases the risk of perioperative morbidity and mortality. Consensus guidelines recommend delaying elective major surgery after acute SARS-CoV-2 infection for 7 or 8 weeks. However, because of the growing backlog of untreated surgical disease and the potential risks of delaying surgery, surgical services may be under pressure to reduce this period. Here, we discuss the risks and benefits of delaying surgery for patients with current or recent SARS-CoV-2 infection in the context of the evolving COVID-19 pandemic, the limited evidence supporting delays to surgery, and the need for more research in this area.
目前或近期感染 SARS-CoV-2 会增加围手术期发病率和死亡率。共识指南建议在急性 SARS-CoV-2 感染后延迟 7 或 8 周进行择期大手术。然而,由于未治疗的手术疾病积压增加,以及延迟手术的潜在风险,外科服务可能面临缩短这一时期的压力。在这里,我们讨论了在 COVID-19 大流行不断演变的背景下,对当前或近期 SARS-CoV-2 感染患者延迟手术的风险和益处,以及支持手术延迟的有限证据,以及该领域需要更多研究。